Skip to main content
. 2023 Jun 22;177(8):790–799. doi: 10.1001/jamapediatrics.2023.2168

Table 1. Meta-analyses of Depression Symptom Severity Stratified by Categorical Study-Level Characteristics.

Variable No. SMD (95% CI) I 2 Test of interaction (P value)
Cohorts Cancer Control
Overall 21 6717 22 607 0.23 (0.09 to 0.37) 92% NA
Survivors, in remission 16 6491 21 367 0.18 (0.02 to 0.33) 93% .13
Undergoing or recent treatment 5 226 1240 0.44 (0.13 to 0.74) 76%
Age at diagnosis <5 y 2 510 2899 −0.20 (−0.56 to 0.17) 0 .04
Age at diagnosis between 5 and 12 y 5 332 794 0.14 (−0.12 to 0.41) 74%
Age at diagnosis between 12 and 18 y 1 56 391 0.61 (0.33 to 0.90) NA
Age at data collection between 5 and 12 y 1 58 64 0.15 (0.75 to 0.46) NA .75
Age at data collection between 12 and 18 y 3 767 1075 0.23 (0.09 to 0.55) 91%
Age at data collection between 18 and 25 y 7 1381 2163 0.12 (0.11 to 0.34) 63%
Age at data collection >25 y 5 4385 9432 0.10 (0.15 to 0.34) 92%
Continent of study: Europe 9 1102 2918 0.30 (0.06 to 0.53) 93% .87
Continent of study: North America 8 5362 17 757 0.41 (0.16 to 0.65) 87%
Continent of study: Asia 3 235 1914 0.25 (−0.15 to 0.65) 74%
Compared with matched controls 17 1702 13 349 0.12 (0.10 to 0.43) 89% .41
Compared with siblings 4 5015 9258 0.26 (0.17 to 0.42) 94%

Abbreviations: NA, not applicable; SMD, standardized mean difference.